Hepatitis A is a liver infection that is caused by the Hepatitis A virus (HAV). The virus primarily spreads when an uninfected (and unvaccinated) person ingests food or water that is contaminated with the feces of an infected person. The infection is highly contagious, but not typically serious, and can be prevented through vaccination. The presence of HAV IgM antibodies in the blood indicates a recent infection with Hepatitis A.

Test Name Hepatitis A Virus (HAV) IgM
Sample Type Blood
Preparations Required No specific preparation is required for this test
Report Time 6 hours

HAV IgM antibodies are the first antibodies that are produced by the body in response to a Hepatitis A infection. They can usually be detected in the blood about 2-3 weeks after you catch the virus and can last about 2-6 months. The presence of these antibodies can be used to detect and diagnose an active or recent Hepatitis A infection.

Home Sample Collection Process

Book your convenient slot

Sample Collection by Phlebotomist

Reporting of the sample at lab

Download Reports

Frequently Asked Questions

What is the importance of the Hepatitis A Virus (HAV) IgM test?

The HAV IgM test is crucial for the timely diagnosis of a recent or ongoing Hepatitis A infection. Early detection allows for the appropriate medical intervention, reducing the severity of symptoms, and preventing the spread of the infection to others.

What does it mean if I test positive for HAV IgM antibodies?

A positive result for HAV IgM antibodies indicates that you have an active or recent Hepatitis A infection. It suggests that the infection occurred recently, as IgM antibodies are generally produced early in the infection.

Sprint Diagnostics

Your cart is empty

Looks like you haven't added any test / checkup to your cart

Add Test / Checkup

Hepatitis B Virus - Drug Resistance

Home
Hyderabad
Lab Test
Hepatitis B Virus - Drug Resistance

Hepatitis B Virus (HBV) infection is a liver infection caused by the hepatitis B virus. Chronic HBV infection can lead to liver cirrhosis, liver failure, and liver cancer. Antiviral medications such as Lamivudine, Telbivudine, Adefovir, Tenofovir, and Entecavir are used to manage HBV infection. However, over time, the virus can develop resistance to these medications. The Hepatitis B Virus - Drug Resistance test detects genetic mutations in the virus that are responsible for resistance to these antiviral drugs. This test is crucial for individuals who are undergoing treatment for chronic HBV infection as it helps doctors to tailor the treatment according to the virus's resistance pattern.

Test Name Hepatitis B Virus (HBV) - Drug Resistance (Lamivudine, Telbivudine, Adefovir, Tenofovir, and Entecavir)
Sample Type Blood
Preparations Required No special preparation is required for this test. However, it is advised to inform your doctor of any medications or supplements you are taking.
Report Time 5 days

Drug resistance can occur when the virus mutates, and these mutations allow it to replicate even in the presence of antiviral drugs. Detecting these mutations early helps in adjusting the treatment plan accordingly, preventing the virus from causing further liver damage and avoiding ineffective treatments.

Home Sample Collection Process

Book your convenient slot

Sample Collection by Phlebotomist

Reporting of the sample at lab

Download Reports

Frequently Asked Questions

What is the Hepatitis B Virus - Drug Resistance test?

This test analyzes the genetic material of the hepatitis B virus to identify mutations that can cause resistance to antiviral medications, including Lamivudine, Telbivudine, Adefovir, Tenofovir, and Entecavir.

Why is this test important?

The test is essential for individuals undergoing treatment for chronic HBV infection. Knowing whether the virus has developed resistance to a particular medication is crucial for adjusting the treatment plan and preventing further liver damage.

Who should undergo the HBV Drug Resistance test?

Patients with chronic HBV infection who are on antiviral therapy and those who show signs of treatment failure or have elevated liver enzymes despite treatment should consider this test.

How is this test performed?

A blood sample is drawn from a vein in the arm. The sample is then analyzed in a laboratory for the presence of genetic mutations that are indicative of drug resistance.

What do the results mean?

If the test detects mutations in the virus's genetic material, it indicates that the virus may be resistant to one or more antiviral medications. Your doctor will use this information to adjust your treatment plan.

Can drug resistance be prevented?

Drug resistance can sometimes be minimized by strictly adhering to the medication regimen and monitoring viral load and liver enzymes regularly.

What happens if the virus is resistant to medication?

If the virus is resistant to a particular medication, your doctor might change your treatment to a different antiviral drug that the virus is sensitive to.

Is it necessary to repeat this test?

Your doctor might recommend repeating this test if there is evidence of treatment failure or if your viral load increases despite therapy.

What are the symptoms of chronic HBV infection?

Chronic HBV infection often has no symptoms in the early stages. Later, symptoms may include fatigue, jaundice, abdominal pain, and nausea.

Are there other tests that should be done along with this test?

Yes, this test is often done alongside other tests, such as HBV viral load, liver function tests, and sometimes liver imaging studies.

Is fasting required for this test?

No, fasting is not required for this test.

Can I take my regular medications before the test?

It is crucial to inform your doctor about all the medications and supplements you are taking, as some of them might interfere with the test results.

Which doctor should I consult if my test results indicate drug resistance?

If the test results indicate drug resistance, you should consult a hepatologist or an infectious disease specialist.

What is the impact of drug resistance on the progression of HBV infection?

Drug resistance can lead to a relapse or progression of HBV infection and can result in liver damage, liver cirrhosis, and liver cancer.

Can drug-resistant HBV be transmitted to others?

Yes, drug-resistant strains of HBV can be transmitted to others through blood or other body fluids.

Understanding the susceptibility of the hepatitis B virus to antiviral medications is key in effectively managing chronic HBV infection. Regular monitoring and appropriate adjustments to the treatment regimen are essential to prevent the progression of liver disease. Patient compliance and open communication with the doctor are critical components for the successful management of chronic HBV infection.

Book Your Slot